Cellectis Files Form 6-K with SEC
Ticker: CLLS · Form: 6-K · Filed: Nov 5, 2024 · CIK: 1627281
Sentiment: neutral
Topics: sec-filing, foreign-private-issuer, routine-disclosure
TL;DR
Cellectis filed a 6-K, confirming 20-F annual reports and Paris HQ. Standard stuff.
AI Summary
Cellectis S.A. filed a Form 6-K on November 5, 2024, to report information as a foreign private issuer. The filing indicates that Cellectis is submitting its report under the 1934 Securities Exchange Act and will file its annual reports under cover of Form 20-F. The company's principal executive office is located at 8, rue de la Croix Jarry, 75013 Paris, France.
Why It Matters
This filing is a routine disclosure for foreign private issuers, confirming their reporting obligations and providing basic company information to the SEC and investors.
Risk Assessment
Risk Level: low — This filing is a standard procedural report for a foreign private issuer and does not contain new financial or operational information that would typically impact risk.
Key Players & Entities
- Cellectis S.A. (company) — Registrant
- 8, rue de la Croix Jarry, 75013 Paris, France (location) — Principal executive office
- Form 6-K (document) — Filing type
- Form 20-F (document) — Annual report cover
- 1934 Securities Exchange Act (regulation) — Governing act
FAQ
What is the purpose of this Form 6-K filing by Cellectis S.A.?
The Form 6-K is a report of a foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, used to provide information to the SEC.
Which form does Cellectis S.A. use for its annual reports?
Cellectis S.A. indicates it files its annual reports under cover of Form 20-F.
Where is Cellectis S.A.'s principal executive office located?
Cellectis S.A.'s principal executive office is located at 8, rue de la Croix Jarry, 75013 Paris, France.
What is the Commission File Number for Cellectis S.A.'s SEC filings?
The Commission File Number for Cellectis S.A. is 001-36891.
Does Cellectis S.A. have any specific operational or financial updates in this filing?
This Form 6-K filing does not appear to contain specific operational or financial updates; it serves as a routine report of a foreign private issuer.
Filing Stats: 157 words · 1 min read · ~1 pages · Grade level 9.8 · Accepted 2024-11-05 16:35:05
Filing Documents
- f6k_110524.htm (6-K) — 6KB
- exh_991.htm (EX-99.1) — 8KB
- 0001171843-24-006021.txt ( ) — 15KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Cellectis S.A. (Registrant) Date: November 5, 2024 /s/ Andr Choulika Andr Choulika Chief Executive Officer